When It Rains It Pours... We are witnessing outpouring of excellent phase 2 results from many corners of the Alzheimer's and neurodegenerative field. The question now is; who is the best bet? The capital behaves like a loose cannon ball on a ship in rough seas, swinging from one company to another. I am primarily … Continue reading Neurotrophic Factors In Curing Alzheimer’s and Other Neurodegenerative Diseases. $SNPX $AVXL $ATHA

Baseline in $SAVA data and the same in $AVXL Phase 2a data. Picture first. There seems to be a discrepancy from calculated ADAS-Cog/MMSE baseline numbers. By ADAS-Cog11 numbers the patients in $SAVA's trial are a bit better off than the data on MMSE tests would suggests. It is difficult to interpret the data as these … Continue reading Cassava Science Results vs. Anavex Life Sciences Projections $SAVA $AVXL